NEW YORK (GenomeWeb News) – Transgenomic said this week that it has agreed to distribute BioView’s scanning and imaging analysis workstations in Western Europe and in Scandinavia.
 
Under the agreement, Transgenomic’s European sales and support arm will market, sell, and service Bioview’s Duet, Allegro, and Accord automated workstation products. The instruments scan and classify cells using fluorescence in situ hybridization and brighlight microscopy.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.